Literature DB >> 2623792

Urinary antibody response after immunisation with a vaccine against urinary tract infection.

D Kruze1, K Holzbecher, M Andrial, W Bossart.   

Abstract

Immunisation of mice with SolcoUrovac vaccine induced an approximately 10-fold increase of the total amount of IgG and a 2-fold increase of IgA immunoglobulins in urine. IgG antibodies to SolcoUrovac antigens appeared in urine after the first injection, and booster injections caused a further increase of the titer. IgA antibodies appeared in the urine after the second injection, and the third injection doubled the titer. IgM immunoglobulins and specific IgM class antibodies to SolcoUrovac were not found in any urine tested. The exact origin of the immunoglobulins in the urine as well as the specificity of immune response is discussed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2623792     DOI： 10.1007/bf00510527

Source DB:  PubMed          Journal:  Urol Res        ISSN： 0300-5623


  25 in total

1.  Antibody-coated bacteria.

Authors:  L W Rumans; K L Vosti
Journal:  JAMA       Date:  1977-02-07       Impact factor: 56.272

2.  Immunoglobulin synthesis in lower urinary tract infection.

Authors:  W L Hand; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Lab Clin Med       Date:  1970-01

3.  Carbohydrate receptor structures recognized by uropathogenic E. coli.

Authors:  G Källenius; S B Svenson; R Möllby; T Korhonen; J Winberg; B Cedergren; I Helin; H Hultberg
Journal:  Scand J Infect Dis Suppl       Date:  1982

4.  Prevention of pyelonephritis by immunization with P-fimbriae.

Authors:  J A Roberts; K Hardaway; B Kaack; E N Fussell; G Baskin
Journal:  J Urol       Date:  1984-03       Impact factor: 7.450

5.  Protection against experimental pyelonephritis by antibodies to pili.

Authors:  F J Silverblatt; R Weinstein; P Rene
Journal:  Scand J Infect Dis Suppl       Date:  1982

6.  Local immune response to Escherichia coli pili in experimental pyelonephritis.

Authors:  J W Smith; S Wagner; R M Swenson
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Local immune response in experimental pyelonephritis.

Authors:  J D Lehmann; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

8.  Elevation of secretory IgA antibodies in the urinary tract by immunostimulation for the pre-operative treatment and post-operative prevention of urinary tract infections.

Authors:  H Rüttgers; E Grischke
Journal:  Urol Int       Date:  1987       Impact factor: 2.089

9.  Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

10.  Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters.

Authors:  J W Warren; D Damron; J H Tenney; J M Hoopes; B Deforge; H L Muncie
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226
View more
  11 in total

1.  Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

Authors:  Davide De Vita; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-05-22       Impact factor: 2.894

2.  Protection by a polyvalent vaccine against challenge infection and pyelonephritis.

Authors:  D Kruze; K Biro; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1992

3.  UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.

Authors:  Christina A Sarkissian; Christopher J Alteri; Harry L T Mobley
Journal:  Vaccine       Date:  2019-07-15       Impact factor: 3.641

Review 4.  Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Authors:  Ariel R Brumbaugh; Harry L T Mobley
Journal:  Expert Rev Vaccines       Date:  2012-06       Impact factor: 5.217

5.  Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.

Authors:  D Cohen; N Orr; G Robin; R Slepon; S Ashkenazi; I Ashkenazi; J Shemer
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

6.  Evaluation of the effects of ozone therapy on Escherichia coli-induced cytitis in rat.

Authors:  C Tasdemir; S Tasdemir; N Vardi; B Ates; Y Onal; S Erdogan; A Yucel; E Aglamis; Y Yakupogullari; R Altıntas; A Karaman
Journal:  Ir J Med Sci       Date:  2013-03-01       Impact factor: 1.568

Review 7.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

8.  Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis.

Authors:  Davide De Vita; Henrik Antell; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-11-06       Impact factor: 2.894

Review 9.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

Review 10.  The immune response to infection in the bladder.

Authors:  Livia Lacerda Mariano; Molly A Ingersoll
Journal:  Nat Rev Urol       Date:  2020-07-13       Impact factor: 16.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.